Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Buy
213,635
+21,559
+11% +$2.67M 0.8% 28
2025
Q4
$24.2M Buy
192,076
+22,476
+13% +$2.93M 0.69% 29
2025
Q3
$24.5M Buy
169,600
+16,150
+11% +$2.44M 0.74% 36
2025
Q2
$24M Buy
153,450
+17,624
+13% +$2.79M 0.78% 34
2025
Q1
$22.2M Buy
135,826
+128,186
+1,678% +$21.3M 0.92% 34
2024
Q4
$1.24M Sell
7,640
-67
-0.9% -$12K 0.01% 150
2024
Q3
$1.5M Buy
7,707
+1,410
+22% +$260K 0.06% 125
2024
Q2
$1.09M Buy
6,297
+3,931
+166% +$654K 0.05% 137
2024
Q1
$401K Buy
+2,366
New +$443K 0.02% 214

Other funds holding ZTS

BNP Paribas's ZTS Position: Q1 2026 in Review

BNP Paribas increased its Zoetis (ZTS) stake by 11% in Q1 2026, buying an estimated $2.67M and bringing the position to 213,635 shares worth $25.1M. The position accounts for 0.8% of the portfolio, ranked #28.

BNP Paribas first reported a position in ZTS in Q1 2024 and has held it in 9 quarters since. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • BNP Paribas held 213,635 shares of Zoetis worth $25.1M as of Q1 2026.
  • BNP Paribas bought 21,559 Zoetis shares in Q1 2026, an estimated $2.67M.
  • Zoetis made up 0.8% of BNP Paribas's portfolio in Q1 2026, its #28 holding.
  • BNP Paribas first reported a position in Zoetis in Q1 2024 and has held it in 9 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.